20
Participants
Start Date
November 10, 2023
Primary Completion Date
April 30, 2026
Study Completion Date
July 31, 2026
Freestyle Libre 3 Continuous Glucose Monitor (CGM)
Subjects will be provided a Freestyle Libre 3 CGM for monitoring of blood glucose levels throughout participation in the study (approximately 3 months). CGM data will be uploaded to the LibreLink app on a weekly basis for review of glucose control and consultation with a diabetes-trained provider for any values outside of normal ranges. Adjustments to diet and medication therapy (antihyperglycemic therapy) will be made during consultations to improve episodes of hypoglycemia or severe hyperglycemia that were observed.
RECRUITING
Mayo Clinic in Rochester, Rochester
Lead Sponsor
Mayo Clinic
OTHER